On November 18, 2025, the US FDA approved Redemplo (R) (plozasiran) a subcutaneous injection indicated for the treatment of a genetic disorder that causes extremely high levels of fat in the …

Micromedex® is more than a drug database. The robust evidence-based solutions and resources help inform clinical decisions throughout the patient care continuum, helping clinicians to enhance patient …

Nov 18, 2025 · Micromedex Overview - A comprehensive drug-based resource also spanning diseases, acute care, toxicology, alternative medicines, and patient education materials.

Micromedex CareNotes provide easy-to-understand information on standard treatments for various diseases and conditions. These resources cover the nature of conditions, potential causes, signs & …

Micromedex facilitates evidence-based decision making in the areas of drug selection, disease and condition management, toxicology, and alternative medicine. It even addresses specific questions, …

Log in to continue to Micromedex. - Your application access has been updated to include additional resources of the Micromedex home page: the latest news, a training and support center, as well as …

May 2, 2025 · The Micromedex suite is a current, reliable, and robust solution to support informed clinical decisions with fast access to the latest evidence-based insights at the point of care. The …

Micromedex is a comprehensive clinical decision support system that is best suited for healthcare professionals, including pharmacists, nurses, and physicians, who need access to evidence-based …

Type the drug name (brand or generic) in the search field. Select the drug and click the (Add) button. Server Working. Capitalized item with asterisk (*) indicates allergy.

Discover the expertly designed IV compatibility checker from Micromedex for safe medication administration, powered by Trissel’s, and available on-the-go.